Your browser doesn't support javascript.
loading
Compression Therapy for HIV-Associated Kaposi Sarcoma Leg Lymphedema: Results of the Kenyan Improvised Compression for Kaposi Sarcoma Randomized Controlled Trial.
Chang, Aileen Y; Karwa, Rakhi; Odhiambo, Haji; Were, Phelix; Fletcher, Sara L; Tonui, Edith C; Kohn, Michael A; Lee, Jeannette; Chang, Di; Lensing, Shelly; Namaemba, Diana Flora; Busakhala, Naftali; Kiprono, Samson K; Maurer, Toby; Goodrich, Suzanne; Pastakia, Sonak D.
Affiliation
  • Chang AY; University of California, San Francisco School of Medicine, Department of Dermatology, San Francisco, CA.
  • Karwa R; Zuckerberg San Francisco General Hospital and Trauma Center, Department of Dermatology, San Francisco, CA.
  • Odhiambo H; AMPATH (Academic Model Providing Access to Healthcare), Eldoret, Kenya.
  • Were P; AMPATH (Academic Model Providing Access to Healthcare), Eldoret, Kenya.
  • Fletcher SL; Purdue University School of Pharmacy, Department of Pharmacy Practice, Center for Health Equity and Innovation, Indianapolis, IN.
  • Tonui EC; Moi University School of Medicine, Department of Pharmacology, Eldoret, Kenya.
  • Kohn MA; AMPATH (Academic Model Providing Access to Healthcare), Eldoret, Kenya.
  • Lee J; AMPATH (Academic Model Providing Access to Healthcare), Eldoret, Kenya.
  • Chang D; Oregon State University College of Pharmacy, Corvallis, OR.
  • Lensing S; Kericho County Referral Hospital, Pharmacy Department, Kericho, Kenya.
  • Namaemba DF; University of California, San Francisco School of Medicine, Department of Epidemiology & Biostatistics, San Francisco, CA.
  • Busakhala N; University of Arkansas for Medical Sciences, Department of Biostatistics, Little Rock, AR.
  • Kiprono SK; University of Arkansas for Medical Sciences, Department of Biostatistics, Little Rock, AR.
  • Maurer T; University of Arkansas for Medical Sciences, Department of Biostatistics, Little Rock, AR.
  • Goodrich S; AMPATH (Academic Model Providing Access to Healthcare), Eldoret, Kenya.
  • Pastakia SD; AMPATH (Academic Model Providing Access to Healthcare), Eldoret, Kenya.
JCO Glob Oncol ; 8: e2100329, 2022 01.
Article in En | MEDLINE | ID: mdl-35025687
ABSTRACT

PURPOSE:

Evaluate the effectiveness of compression while receiving chemotherapy compared with chemotherapy alone in the treatment of HIV-associated Kaposi sarcoma (KS) lymphedema.

METHODS:

A randomized controlled trial was conducted in a single oncology clinic in western Kenya (NCT03404297). A computer-generated randomization schedule was used to allocate treatment arms. Randomized block design was used for stratification by lymphedema stage. Participants were HIV positive adults age ≥ 18 years on antiretroviral therapy with biopsy-proven KS associated with leg lymphedema and being initiated on chemotherapy. The intervention was 10 weeks of weekly clinic-based application of two-component paste compression bandages. The primary outcome was change in the Lower Extremity Lymphedema Index (LELI) score from week 0 to week 14. The secondary outcomes were change in the Lymphedema Quality of Life measure (LYMQOL) and change in the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-C30 score from week 0 to week 14. Blinded outcome assessments were conducted.

RESULTS:

Of 30 participants randomly assigned, 25 eligible patients (chemotherapy [control], n = 13; compression plus chemotherapy [intervention], n = 12) returned at week 14. Change in LELI, LYMQOL, and EORTC QLQ-C30 scores between week 14 and week 0 did not significantly differ by arm. The mean (standard deviation) change in LELI score was -25.9 (34.6) for the control arm compared with -13.3 (29.5) for the intervention arm, P = .340. The difference (95% CI) in the change in LELI score was -12.6 (-39.3 to 14.1).

CONCLUSION:

Future studies evaluating a 14-week change in LELI for KS lymphedema should assume a standard deviation of approximately 30. Lessons learned from this pilot trial should inform the development of a larger, multicenter trial to evaluate the effectiveness of compression for KS lymphedema.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sarcoma, Kaposi / HIV Infections / Lymphedema Type of study: Clinical_trials / Risk_factors_studies Aspects: Patient_preference Limits: Adolescent / Adult / Humans Country/Region as subject: Africa Language: En Journal: JCO Glob Oncol Year: 2022 Document type: Article Affiliation country: Canada

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sarcoma, Kaposi / HIV Infections / Lymphedema Type of study: Clinical_trials / Risk_factors_studies Aspects: Patient_preference Limits: Adolescent / Adult / Humans Country/Region as subject: Africa Language: En Journal: JCO Glob Oncol Year: 2022 Document type: Article Affiliation country: Canada
...